These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

757 related articles for article (PubMed ID: 34350893)

  • 1. Possible Therapeutic Potential of Cysteinyl Leukotriene Receptor Antagonist Montelukast in Treatment of SARS-CoV-2-Induced COVID-19.
    Dey M; Singh RK
    Pharmacology; 2021; 106(9-10):469-476. PubMed ID: 34350893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Leukotriene Receptor Antagonist Montelukast Reduces Alpha-Synuclein Load and Restores Memory in an Animal Model of Dementia with Lewy Bodies.
    Marschallinger J; Altendorfer B; Rockenstein E; Holztrattner M; Garnweidner-Raith J; Pillichshammer N; Leister I; Hutter-Paier B; Strempfl K; Unger MS; Chishty M; Felder T; Johnson M; Attems J; Masliah E; Aigner L
    Neurotherapeutics; 2020 Jul; 17(3):1061-1074. PubMed ID: 32072462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Montelukast and Coronavirus Disease 2019: A Scoping Review.
    Sharifinejad N; Sharafian S; Salekmoghadam S; Tavakol M; Qorbani M
    Iran J Allergy Asthma Immunol; 2021 Aug; 20(4):384-393. PubMed ID: 34418892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between obesity and poor outcome after COVID-19 indicates a potential therapeutic role for montelukast.
    Almerie MQ; Kerrigan DD
    Med Hypotheses; 2020 Oct; 143():109883. PubMed ID: 32492562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. As a potential treatment of COVID-19: Montelukast.
    Fidan C; Aydoğdu A
    Med Hypotheses; 2020 Sep; 142():109828. PubMed ID: 32416408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of leukotriene pathway and montelukast in pulmonary and extrapulmonary manifestations of Covid-19: The enigmatic entity.
    Al-Kuraishy HM; Al-Gareeb AI; Almulaiky YQ; Cruz-Martins N; El-Saber Batiha G
    Eur J Pharmacol; 2021 Aug; 904():174196. PubMed ID: 34004207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cysteinyl leukotriene receptor-1 as a potential target for host-directed therapy during chronic schistosomiasis in murine model.
    Mosala P; Mpotje T; Abdel Aziz N; Ndlovu H; Musaigwa F; Nono JK; Brombacher F
    Front Immunol; 2024; 15():1279043. PubMed ID: 38840916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ameliorating effect of leukotriene receptor antagonist in multi-organ toxicity induced in rat offspring, a possible role for epidermal growth factor.
    Abdelzaher WY; Rofaeil RR; Abdel-Hafez SMN; Atta M; Bahaa El-Deen MA; Ali DM
    Immunopharmacol Immunotoxicol; 2021 Apr; 43(2):183-191. PubMed ID: 33504223
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanisms underlying the protective effect of leukotriene receptor antagonist montelukast against doxorubicin induced testicular injury in rats.
    Mohamed MZ; Zenhom NM
    Prostaglandins Other Lipid Mediat; 2020 Aug; 149():106447. PubMed ID: 32173485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Montelukast drug activity and potential against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
    Copertino DC; Duarte RRR; Powell TR; de Mulder Rougvie M; Nixon DF
    J Med Virol; 2021 Jan; 93(1):187-189. PubMed ID: 32658304
    [No Abstract]   [Full Text] [Related]  

  • 11. Montelukast as a potential treatment for COVID-19.
    McCarthy MW
    Expert Opin Pharmacother; 2023 Apr; 24(5):551-555. PubMed ID: 36927284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Montelukast: more than a cysteinyl leukotriene receptor antagonist?
    Tintinger GR; Feldman C; Theron AJ; Anderson R
    ScientificWorldJournal; 2010 Dec; 10():2403-13. PubMed ID: 21170491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral activity against Middle East Respiratory Syndrome coronavirus by Montelukast, an anti-asthma drug.
    Gan HJ; Harikishore A; Lee J; Jeon S; Rajan S; Chen MW; Neo JL; Kim S; Yoon HS
    Antiviral Res; 2021 Jan; 185():104996. PubMed ID: 33309540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of the therapeutic potential of the cysteinyl leukotriene antagonist Montelukast in the treatment of bronchiolitis obliterans syndrome following lung and hematopoietic-stem cell transplantation and its possible mechanisms.
    Kordjazy N; Amini S
    Ther Adv Respir Dis; 2024; 18():17534666241232284. PubMed ID: 38504551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levocetirizine and montelukast in the COVID-19 treatment paradigm.
    May BC; Gallivan KH
    Int Immunopharmacol; 2022 Feb; 103():108412. PubMed ID: 34942461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Montelukast in pediatric asthma management.
    Walia M; Lodha R; Kabra SK
    Indian J Pediatr; 2006 Apr; 73(4):275-82. PubMed ID: 16816486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuromodulatory effects of leukotriene receptor antagonists: A comprehensive review.
    Sood R; Anoopkumar-Dukie S; Rudrawar S; Hall S
    Eur J Pharmacol; 2024 Sep; 978():176755. PubMed ID: 38909933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Montelukast, a cysteinyl leukotriene receptor antagonist, exerts local antinociception in animal model of pain through the L-arginine/nitric oxide/cyclic GMP/K
    Alizamani E; Ghorbanzadeh B; Naserzadeh R; Mansouri MT
    Int J Neurosci; 2021 Oct; 131(10):1004-1011. PubMed ID: 32408781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukotriene receptor antagonism with montelukast as a possible therapeutic for venous thromboembolism prophylaxis: An observational study.
    Sutton SS; Magagnoli J; Cummings TH; Hardin JW
    Prostaglandins Other Lipid Mediat; 2022 Aug; 161():106649. PubMed ID: 35595009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
    Shimbori C; Shiota N; Okunishi H
    Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.